NDC 0002-6120 – Retevmo
Selpercatinib 120 mg/1 · Tablet, Coated · Oral
Product NDC0002-6120
Product details
- Brand name
- Retevmo
- Generic name
- Selpercatinib
- Labeler
- Eli Lilly and Company
- Dosage form
- Tablet, Coated
- Route
- Oral
- Marketing category
- NDA · NDA218160
- Marketed since
- April 10, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Selpercatinib 120 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0002-6120-60 | 60 TABLET, COATED in 1 BOTTLE (0002-6120-60) | Apr 10, 2024 |
Other Retevmo products
- 0002-5340 Selpercatinib 40 mg/1 · Tablet, Coated · Eli Lilly and Company
- 0002-5562 Selpercatinib 160 mg/1 · Tablet, Coated · Eli Lilly and Company
- 0002-6082 Selpercatinib 80 mg/1 · Tablet, Coated · Eli Lilly and Company
- 0002-2980 Selpercatinib 80 mg/1 · Capsule · Eli Lilly and Company
- 0002-3977 Selpercatinib 40 mg/1 · Capsule · Eli Lilly and Company